BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 17066403)

  • 1. Re: vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival by Tzanakis N, Gazouli M, Rallis G, et al.
    Demetrick DJ
    J Surg Oncol; 2006 Dec; 94(7):549-50. PubMed ID: 17066403
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular endothelial growth factor polymorphisms in gastric cancer development, prognosis, and survival.
    Tzanakis N; Gazouli M; Rallis G; Giannopoulos G; Papaconstantinou I; Theodoropoulos G; Pikoulis E; Tsigris C; Karakitsos P; Peros G; Nikiteas N
    J Surg Oncol; 2006 Dec; 94(7):624-30. PubMed ID: 17111394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric cancer risk predisposition and prognostic significance of vascular endothelial growth factor (VEGF) gene polymorphisms--a case-control study in an Omani population.
    Al-Moundhri MS; Al-Nabhani M; Burney IA; Al-Farsi AA; Al-Bahrani B
    Mol Carcinog; 2009 Dec; 48(12):1170-6. PubMed ID: 19676106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of polymorphisms in the 3' untranslated region (3'-UTR) of vascular endothelial growth factor gene on gastric cancer and peptic ulcer diseases in Japan.
    Tahara T; Shibata T; Nakamura M; Yamashita H; Yoshioka D; Hirata I; Arisawa T
    Mol Carcinog; 2009 Nov; 48(11):1030-7. PubMed ID: 19496079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentially functional polymorphisms of the vascular endothelial growth factor gene and risk of gastric cancer.
    Ke Q; Liang J; Wang LN; Hu ZB; Jin GF; Zhou Y; Wang JM; Tan YF; Hua ZL; Xu YC; Shen J; Shen HB
    Mol Carcinog; 2008 Aug; 47(8):647-51. PubMed ID: 18383582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical implication of vascular endothelial growth factor T-460C polymorphism in the risk and progression of prostate cancer.
    Fukuda H; Tsuchiya N; Narita S; Kumazawa T; Horikawa Y; Inoue T; Saito M; Yuasa T; Matsuura S; Satoh S; Ogawa O; Habuchi T
    Oncol Rep; 2007 Nov; 18(5):1155-63. PubMed ID: 17914566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
    Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
    Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RUNX3 inhibits the expression of vascular endothelial growth factor and reduces the angiogenesis, growth, and metastasis of human gastric cancer.
    Peng Z; Wei D; Wang L; Tang H; Zhang J; Le X; Jia Z; Li Q; Xie K
    Clin Cancer Res; 2006 Nov; 12(21):6386-94. PubMed ID: 17085650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor gene polymorphisms in ovarian cancer.
    Polterauer S; Grimm C; Mustea A; Concin N; Tanner B; Thiel F; Heinze G; Reinthaller A; Zeillinger R; Hefler LA
    Gynecol Oncol; 2007 May; 105(2):385-9. PubMed ID: 17289129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of vascular endothelial growth factor (VEGF) and epidermal growth factor receptor (EGFR) is an independent prognostic indicator of worse outcome in gastric cancer patients.
    Lieto E; Ferraraccio F; Orditura M; Castellano P; Mura AL; Pinto M; Zamboli A; De Vita F; Galizia G
    Ann Surg Oncol; 2008 Jan; 15(1):69-79. PubMed ID: 17896140
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival.
    Dassoulas K; Gazouli M; Rizos S; Theodoropoulos G; Christoni Z; Nikiteas N; Karakitsos P
    Mol Carcinog; 2009 Jun; 48(6):563-9. PubMed ID: 19009560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor gene polymorphisms are associated with prognosis in ovarian cancer.
    Hefler LA; Mustea A; Könsgen D; Concin N; Tanner B; Strick R; Heinze G; Grimm C; Schuster E; Tempfer C; Reinthaller A; Zeillinger R
    Clin Cancer Res; 2007 Feb; 13(3):898-901. PubMed ID: 17289883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional vascular endothelial growth factor -2578 C/A polymorphism in relation to nasopharyngeal carcinoma risk and tumor progression.
    Nasr HB; Chahed K; Bouaouina N; Chouchane L
    Clin Chim Acta; 2008 Sep; 395(1-2):124-9. PubMed ID: 18588866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
    Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of polymorphisms of angiogenesis genes with breast cancer.
    Clar H; Krippl P; Renner W; Langsenlehner T; Clar V; Windhager R; Langsenlehner U
    Breast Cancer Res Treat; 2009 Jan; 113(1):197-8. PubMed ID: 18210198
    [No Abstract]   [Full Text] [Related]  

  • 16. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
    Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive correlation of osteopontin, cyclooxygenase-2 and vascular endothelial growth factor in gastric cancer.
    Tang H; Wang J; Bai F; Zhai H; Gao J; Hong L; Xie H; Zhang F; Lan M; Yao W; Liu J; Wu K; Fan D
    Cancer Invest; 2008 Feb; 26(1):60-7. PubMed ID: 18181047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
    Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
    J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor polymorphisms in early-stage non-small-cell lung cancer.
    Patel M; Ailawadhi S; Hernandez-Ilizaliturri F; Wilding GE
    J Clin Oncol; 2008 Jul; 26(19):3289-90; author reply 3290. PubMed ID: 18591568
    [No Abstract]   [Full Text] [Related]  

  • 20. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer.
    Hsu PI; Hsieh HL; Lee J; Lin LF; Chen HC; Lu PJ; Hsiao M
    Ann Surg Oncol; 2009 Jun; 16(6):1686-94. PubMed ID: 19290488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.